These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 7703461)

  • 1. [Participation of brain 5-HT1A serotonin receptors in regulating hereditary catalepsy].
    Popova NK; Kulikov AV; Avgustinovich DF; Vishnivetskaia GB; Kolpakov VG
    Biull Eksp Biol Med; 1994 Dec; 118(12):633-5. PubMed ID: 7703461
    [No Abstract]   [Full Text] [Related]  

  • 2. Involvement of striatum serotonergic system in the expression of genetically defined catalepsy.
    Popova NK; Kulikov AV; Avgustinovich DF; Barykina NN
    Ross Fiziol Zh Im I M Sechenova; 1997; 83(5-6):66-79. PubMed ID: 13677667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel benzodioxopiperazines acting as antagonists at postsynaptic 5-HT1A receptors and as agonists at 5-HT1A autoreceptors: a comparative pharmacological characterization with proposed 5-HT1A antagonists.
    Millan MJ; Canton H; Gobert A; Lejeune F; Rivet JM; Bervoets K; Brocco M; Widdowson P; Mennini T; Audinot V
    J Pharmacol Exp Ther; 1994 Jan; 268(1):337-52. PubMed ID: 8301575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin 5-HT1A receptors mediate inhibition of tyrosine hydroxylation in rat striatum.
    Johnson EA; Tsai CE; Shahan YH; Azzaro AJ
    J Pharmacol Exp Ther; 1993 Jul; 266(1):133-41. PubMed ID: 8101215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationship studies of CNS agents. Part 24: New analogs of N-tert.-butyl-3-[4-(2-methoxyphenyl)-1-piperazinyl]-2-phenylpropanamide (WAY-100135).
    Boksa J; Klodzińska A; Charakchieva-Minol S; Chojnacka-Wójcik E; Mokrosz JL
    Pharmazie; 1996 Feb; 51(2):72-6. PubMed ID: 8720802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes in the serotonin system of the brains of rats genetically predisposed to catalepsy].
    Popova NK; Kulikov AV; Kolpakov VG; Barykina NN; Alekhina TA
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1985; 35(4):742-6. PubMed ID: 2413649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The participation of the dopaminergic system of the striatum in the regulation of catalepsy in mice and rats of different genotypes].
    Skrinskaia IuA; Popova NK; Nikulina EM; Kulikov AV
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1997; 47(6):1032-9. PubMed ID: 9472169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatodendritic and postsynaptic serotonin-1A receptors in the attenuation of haloperidol-induced catalepsy.
    Haleem DJ; Shireen E; Haleem MA
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1323-9. PubMed ID: 15588759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of linking bridge modifications on the 5-HT1A receptor activity of some 4-(omega-benzotriazol-1-yl)alkyl-1-(2-methoxy-phenyl)piperazines.
    Paluchowska MH; Kłodzińska A; Tatarczyńska E; Szaro A; Chojnacka-Wójcik E
    Pol J Pharmacol; 1998; 50(4-5):341-7. PubMed ID: 10091719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MP-3022, a new putative antagonist at pre- and postsynaptic 5-HT1A receptors.
    Przegaliński E; Filip M; Bijak M; Wedzony K; Budziszewska B; Tokarski K; Maćkowiak M; Fijał K
    Pol J Pharmacol; 1996; 48(1):13-22. PubMed ID: 9112623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of 5-hydroxytryptamine1A receptors in Delta9-tetrahydrocannabinol-induced catalepsy-like immobilization in mice.
    Egashira N; Matsuda T; Koushi E; Mishima K; Iwasaki K; Shoyama Y; Fujiwara M
    Eur J Pharmacol; 2006 Nov; 550(1-3):117-22. PubMed ID: 17022969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The distribution of serotonin 5-HT1A receptors in the brain of rats genetically predisposed to the development of catalepsy].
    Popova NK; Avgustinovich DF; Shigantsov SN; Kulikov AV
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1996; 46(3):578-82. PubMed ID: 8755064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and structure-activity relationships of a new model of arylpiperazines. 3.1 2-[omega-(4-arylpiperazin-1-yl)alkyl]perhydropyrrolo- [1,2-c]imidazoles and -perhydroimidazo[1,5-a]pyridines: study of the influence of the terminal amide fragment on 5-HT1A affinity/selectivity.
    López-Rodríguez ML; Morcillo MJ; Fernández E; Porras E; Murcia M; Sanz AM; Orensanz L
    J Med Chem; 1997 Aug; 40(16):2653-6. PubMed ID: 9258372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-HT1A receptor-mediated G protein activation assessed by [35S]GTPgammaS binding in rat cerebral cortex.
    Odagaki Y; Toyoshima R
    Eur J Pharmacol; 2005 Oct; 521(1-3):49-58. PubMed ID: 16182280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and structure-activity relationships of a new model of arylpiperazines. 1. 2-[[4-(o-methoxyphenyl)piperazin-1-yl]methyl]-1, 3-dioxoperhydroimidazo[1,5-alpha]pyridine: a selective 5-HT1A receptor agonist.
    López-Rodríguez ML; Rosado ML; Benhamú B; Morcillo MJ; Sanz AM; Orensanz L; Beneitez ME; Fuentes JA; Manzanares J
    J Med Chem; 1996 Oct; 39(22):4439-50. PubMed ID: 8893838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central pre- and postsynaptic 5-HT1A receptors in rats treated chronically with a novel antidepressant, cericlamine.
    Jolas T; Haj-Dahmane S; Kidd EJ; Langlois X; Lanfumey L; Fattaccini CM; Vantalon V; Laporte AM; Adrien J; Gozlan H
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1432-43. PubMed ID: 8138956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orally active benzamide antipsychotic agents with affinity for dopamine D2, serotonin 5-HT1A, and adrenergic alpha1 receptors.
    Reitz AB; Baxter EW; Codd EE; Davis CB; Jordan AD; Maryanoff BE; Maryanoff CA; McDonnell ME; Powell ET; Renzi MJ; Schott MR; Scott MK; Shank RP; Vaught JL
    J Med Chem; 1998 Jun; 41(12):1997-2009. PubMed ID: 9622541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo binding of [123I]4-(2'-methoxyphenyl)-1-[2'-(N-2"-pyridinyl)- p-iodobenzamido-]ethyl-piperazine, p-MPPI, to 5-HT1A receptors in rat brain.
    Kung MP; Zhuang ZP; Frederick D; Kung HF
    Synapse; 1994 Dec; 18(4):359-66. PubMed ID: 7886629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anxiolytic-like effect of a serotonergic ligand with high affinity for 5-HT1A, 5-HT2A and 5-HT3 receptors.
    Delgado M; Caicoya AG; Greciano V; Benhamú B; López-Rodríguez ML; Fernández-Alfonso MS; Pozo MA; Manzanares J; Fuentes JA
    Eur J Pharmacol; 2005 Mar; 511(1):9-19. PubMed ID: 15777774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and structure-activity relationships of a new model of arylpiperazines. 4. 1-[omega-(4-Arylpiperazin-1-yl)alkyl]-3-(diphenylmethylene) - 2, 5-pyrrolidinediones and -3-(9H-fluoren-9-ylidene)-2, 5-pyrrolidinediones: study of the steric requirements of the terminal amide fragment on 5-HT1A affinity/selectivity.
    López-Rodríguez ML; Morcillo MJ; Rovat TK; Fernández E; Vicente B; Sanz AM; Hernández M; Orensanz L
    J Med Chem; 1999 Jan; 42(1):36-49. PubMed ID: 9888831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.